Kakoullis, S. A., Eichenberger, E. M., Steinbrink, J. M., Maziarz, E., Ali, H., Berry, H., … Wolfe, C. R. (2020). Viremic Hepatitis C (HCV) Donors a Viable Option for Lung Transplant Recipients Treated with Real World Delayed Therapy. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 20, pp. 522–523).

Kakoullis, S. A., E. M. Eichenberger, J. M. Steinbrink, E. Maziarz, H. Ali, H. Berry, J. Haney, J. Klapper, J. M. Reynolds, and C. R. Wolfe. “Viremic Hepatitis C (HCV) Donors a Viable Option for Lung Transplant Recipients Treated with Real World Delayed Therapy.” In AMERICAN JOURNAL OF TRANSPLANTATION, 20:522–23, 2020.

Kakoullis SA, Eichenberger EM, Steinbrink JM, Maziarz E, Ali H, Berry H, et al. Viremic Hepatitis C (HCV) Donors a Viable Option for Lung Transplant Recipients Treated with Real World Delayed Therapy. In: AMERICAN JOURNAL OF TRANSPLANTATION. 2020. p. 522–3.

Kakoullis, S. A., et al. “Viremic Hepatitis C (HCV) Donors a Viable Option for Lung Transplant Recipients Treated with Real World Delayed Therapy.” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 20, 2020, pp. 522–23.

Kakoullis SA, Eichenberger EM, Steinbrink JM, Maziarz E, Ali H, Berry H, Haney J, Klapper J, Reynolds JM, Wolfe CR. Viremic Hepatitis C (HCV) Donors a Viable Option for Lung Transplant Recipients Treated with Real World Delayed Therapy. AMERICAN JOURNAL OF TRANSPLANTATION. 2020. p. 522–523.